ADVERTISEMENT
What Makes Cipla Confident About Growth In Next Two Years
One of the key factors for earnings of Cipla and domestic peers is improving business in the U.S. market, says CFO Kedar Upadhye.
08 Feb 2021, 03:05 PM IST
India’s drugmakers’ performance in the U.S., the biggest market for most, is improving as pricing environment is becoming stable, according to the nation’s fourth-largest pharmaceuticals firm by value.One of the key factors for earnings of Cipla Ltd. and its domestic peers is improving business in the American market, Kedar Upadhye, chief financial officer at the drugmaker, told BloombergQuint’s Niraj Shah in an interview. That’s goi...
I’m already a Subscriber Sign In
To continue reading this story
Subscribe to unlock & enjoy all Members-only benefits
Choose a plan
Renews automatically. Cancel anytime.
As a Subscriber you get
Access to
Stories
Curated
Newsletters
20,000+
Research Reports
Priority Pass
to Special Events
Ad-Lite
Experience
Members-Only
Rewards
NDTV Profit
Exclusive Stories
Full Access to
NDTV Profit App
Access to
Stories
20,000+
Research Reports
Ad-Lite
Experience
NDTV Profit
Exclusive Stories
Curated
Newsletters
Priority Pass
to Special Events
Members-Only
Rewards
Full Access to
NDTV Profit App
Still Not convinced ? Know More
Get live Stock market updates, Business news, Today’s latest news, Trending stories, and Videos on NDTV Profit.
ADVERTISEMENT